Drug:
Reaction: VISION BLURRED
20250101 - 20251231
No. 1 - 100
No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
1 | 25492220 |
US |
21 | 2 |
Vision blurred, Asthenia, Cold sweat, Hyperhidrosis, Peripheral coldness, Chills, Nausea, Dizziness, Thirst, Dyspnoea, Pallor, Aphasia, |
||||
TRISODIUM CITRATE DIHYDRATE, |
||||
2 | 25492346 |
US |
2 | |
Choroidal effusion, Angle closure glaucoma, Vision blurred, Intraocular pressure increased, |
||||
BUPROPION HYDROCHLORIDE, ACYCLOVIR, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE, DEXTROAMPHETAMINE SULFATE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE SULFATE AND AMPHETAMINE ASPARTATE, AMOXICILLIN AND CLAVULANATE POTASSIUM, LEVETIRACETAM, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, LEVETIRACETAM IN SODIUM CHLORIDE, LEVOTHYROXINE, MELATONIN, OXYCODONE, POSACONAZOLE, POSACONAZOLE DELAYED-RELEASE, CEDAZURIDINE AND DECITABINE, |
||||
3 | 25492555 |
US |
||
Myalgia, Vision blurred, Insomnia, Headache, Diarrhoea, Drug ineffective, |
||||
VIBEGRON, |
||||
4 | 25492687 |
US |
64 | 1 |
Nephritis, Vision blurred, Off label use, |
||||
PREDNISONE, FLUOROURACIL CREAM, 0.5%, FLUOROURACIL, OXALIPLATIN, TRASTUZUMAB, |
||||
5 | 25492836 |
US |
2 | |
Dry eye, Dark circles under eyes, Anxiety, Vision blurred, |
||||
TRIAMCINOLONE ACETONIDE, |
||||
6 | 25492889 |
US |
2 | |
Tunnel vision, Incontinence, Aphasia, Eye pruritus, Sinus headache, Vision blurred, Confusional state, Eye irritation, Tremor, Underdose, |
||||
NALTREXONE HYDROCHLORIDE AND BUPROPION HYDROCHLORIDE, NALTREXONE HYDROCHLORIDE AND BUPROPION HYDROCHLORIDE, |
||||
7 | 25493672 |
PL |
55 | 1 |
Drug ineffective, Somnolence, Confusional state, Dizziness, Ataxia, Vision blurred, |
||||
CARBAMAZEPINE, PHENYTOIN, CLONAZEPAM, GABAPENTIN, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, |
||||
8 | 25493745 |
US |
||
Product container issue, Off label use, Vision blurred, |
||||
CARBOXYMETHYLCELLULOSE SODIUM AND GLYCERIN, CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN AND POLYSORBATE 80, |
||||
9 | 25494370 |
US |
48 | |
Vision blurred, |
||||
DULAGLUTIDE, |
||||
10 | 25494444 |
CN |
56 | 1 |
Anaphylactic shock, Syncope, Loss of consciousness, Seizure, Vision blurred, Flushing, Blood pressure decreased, Conjunctival oedema, |
||||
IOPROMIDE, |
||||
11 | 25494554 |
CA |
80 | 2 |
Pruritus, Diarrhoea, Vomiting, Urinary tract infection, COVID-19, Depression, Taste disorder, Vision blurred, Dyspnoea, Anxiety, Malaise, Somnolence, Headache, Productive cough, Dry eye, Skin exfoliation, Pain in extremity, Asthenia, Fatigue, Decreased appetite, Weight increased, Weight decreased, Dizziness, Balance disorder, Blood culture positive, Pyrexia, |
||||
12 | 25494597 |
GB |
90 | 2 |
Lip swelling, Oropharyngeal discomfort, Vision blurred, Balance disorder, |
||||
PREGABALIN, PREGABALIN, PREGABALIN, PREGABALIN, MENTHOL, MENTHOL, UNSPECIFIED FORM, COUGH SUPPRESSANT, MAXIMUM STRENGTH MEDICATED FOOT POWDER TALC FREE, AMISH ORIGINS MEDICATED, MAXIMUM STRENGTH MEDICATED FOOT POWDER, MENTHOL, MENTHOL, UNSPECIFIED FORM, COUGH SUPPRESSANT, MAXIMUM STRENGTH MEDICATED FOOT POWDER TALC FREE, AMISH ORIGINS MEDICATED, MAXIMUM STRENGTH MEDICATED FOOT POWDER, MENTHOL, MENTHOL, UNSPECIFIED FORM, COUGH SUPPRESSANT, MAXIMUM STRENGTH MEDICATED FOOT POWDER TALC FREE, AMISH ORIGINS MEDICATED, MAXIMUM STRENGTH MEDICATED FOOT POWDER, MENTHOL, MENTHOL, UNSPECIFIED FORM, COUGH SUPPRESSANT, MAXIMUM STRENGTH MEDICATED FOOT POWDER TALC FREE, AMISH ORIGINS MEDICATED, MAXIMUM STRENGTH MEDICATED FOOT POWDER, TRIMETHOPRIM, TRIMETHOPRIM, TRIMETHOPRIM, TRIMETHOPRIM, CLARITHROMYCIN, CLARITHROMYCIN, CLARITHROMYCIN, CLARITHROMYCIN, SENNOSIDES, SENNOSIDES, SENNOSIDES, SENNOSIDES, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, PERINDOPRIL ERBUMINE, PERINDOPRIL ERBUMINE, PERINDOPRIL ERBUMINE, PERINDOPRIL ERBUMINE, LORATADINE, LORATADINE ORAL, LORATADINE, LORATADINE ORAL, LORATADINE, LORATADINE ORAL, LORATADINE, LORATADINE ORAL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, DOXAZOSIN, DOXAZOSIN MESYLATE, DOXAZOSIN, DOXAZOSIN MESYLATE, DOXAZOSIN, DOXAZOSIN MESYLATE, DOXAZOSIN, DOXAZOSIN MESYLATE, |
||||
13 | 25494642 |
CA |
77 | 1 |
Dehydration, Neuropathy peripheral, Urinary incontinence, Inflammation, Dry mouth, Pain, Discomfort, Decreased activity, Cognitive disorder, Dyskinesia, Defaecation urgency, Muscle spasms, Loss of personal independence in daily activities, Taste disorder, Malaise, Hepatic enzyme increased, Blood copper increased, Abdominal rigidity, Dizziness, Fall, Reflexes abnormal, Head injury, Urine output increased, Abdominal pain, Myalgia, Muscular weakness, Gait disturbance, Vision blurred, Back pain, Constipation, Musculoskeletal pain, Lacrimation increased, Conjunctivitis, Dry eye, Infusion site extravasation, Decreased appetite, Vomiting, Nausea, Rash, Anaemia, Diarrhoea, Fatigue, Decreased appetite, Drug effect less than expected, Product use issue, |
||||
14 | 25494896 |
CA |
29 | 1 |
Condition aggravated, Constipation, Drug ineffective, Haematochezia, Neck pain, Vision blurred, Xerophthalmia, |
||||
ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, |
||||
15 | 25495265 |
US |
71 | 1 |
Burning sensation, Vision blurred, |
||||
PERFLUOROHEXYLOCTANE, CYCLOSPORINE, |
||||
16 | 25495522 |
GB |
90 | 2 |
Vision blurred, Lip swelling, Oropharyngeal discomfort, Balance disorder, |
||||
PREGABALIN, MENTHOL, MENTHOL, UNSPECIFIED FORM, COUGH SUPPRESSANT, MAXIMUM STRENGTH MEDICATED FOOT POWDER TALC FREE, AMISH ORIGINS MEDICATED, MAXIMUM STRENGTH MEDICATED FOOT POWDER, TRIMETHOPRIM, CLARITHROMYCIN, SENNOSIDES, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, PERINDOPRIL ERBUMINE, LORATADINE, LORATADINE ORAL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, DOXAZOSIN, DOXAZOSIN MESYLATE, |
||||
17 | 25495668 |
US |
63 | 2 |
Vision blurred, Condition aggravated, |
||||
DUPILUMAB, DUPILUMAB, |
||||
18 | 25495693 |
US |
73 | 2 |
Abdominal pain upper, Rash pruritic, Vision blurred, Injection site pain, Wrong technique in product usage process, Inappropriate schedule of product administration, |
||||
DUPILUMAB, |
||||
19 | 25495722 |
US |
78 | 2 |
Hospitalisation, Mobility decreased, Vision blurred, |
||||
INSULIN GLARGINE, |
||||
20 | 25495755 |
US |
1 | |
Vision blurred, Condition aggravated, Ocular hyperaemia, Eye pruritus, |
||||
DUPILUMAB, DUPILUMAB, DUPILUMAB, |
||||
21 | 25495798 |
GB |
69 | 2 |
Epistaxis, Headache, Eye swelling, Conjunctivitis, Glossodynia, Eye discharge, Mydriasis, Vision blurred, |
||||
MONTELUKAST SODIUM, MONTELUKAST, FUROSEMIDE, DOXYCYCLINE, DOXYCYCLINE HYCLATE, POTASSIUM CITRATE, ACETAZOLAMIDE SODIUM, ACETAZOLAMIDE, AMITRIPTYLINE HYDROCHLORIDE, AMLODIPINE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, PREGABALIN, TIOTROPIUM BROMIDE, MIRTAZAPINE, LISINOPRIL, BUPRENORPHINE, |
||||
22 | 25495846 |
US |
44 | 1 |
Dizziness, Vision blurred, |
||||
DUPILUMAB, |
||||
23 | 25496006 |
US |
||
Intentional product misuse, Off label use, Vision blurred, |
||||
CYCLOSPORINE, |
||||
24 | 25496182 |
US |
2 | |
Metamorphopsia, Eye irritation, Eye swelling, Eye pain, Ocular hyperaemia, Eye allergy, Eye disorder, Photophobia, Dry eye, Vision blurred, Headache, |
||||
BIMATOPROST, |
||||
25 | 25496484 |
US |
24 | 1 |
Dyspepsia, Vision blurred, |
||||
XANOMELINE AND TROSPIUM CHLORIDE, XANOMELINE AND TROSPIUM CHLORIDE, |
||||
26 | 25491168 |
US |
1 | |
Vision blurred, |
||||
DUPILUMAB, |
||||
27 | 25491392 |
US |
29 | 2 |
Dermatitis atopic, Rash erythematous, Eye pruritus, Vision blurred, |
||||
DUPILUMAB, |
||||
28 | 25500382 |
50 | 2 | |
Eructation, Abdominal pain upper, Diarrhoea haemorrhagic, Dysphagia, Oropharyngeal pain, Bone pain, Vision blurred, Throat tightness, Hernia, Irritable bowel syndrome, Emotional distress, |
||||
DULAGLUTIDE, SEMAGLUTIDE, SERTRALINE HYDROCHLORIDE, PREGABALIN, CALCIUM, |
||||
29 | 25499931 |
30 | 2 | |
Vision blurred, Urinary retention, Application site irritation, Dermatitis, |
||||
SOFPIRONIUM BROMIDE, |
||||
30 | 25500061 |
26 | 1 | |
Withdrawal syndrome, Cognitive disorder, Restlessness, Akathisia, Depersonalisation/derealisation disorder, Weight decreased, Vision blurred, Anhedonia, Anxiety, Agitation, Influenza like illness, Mood swings, Anger, Negative thoughts, Blunted affect, Violence-related symptom, Psychiatric symptom, Lack of empathy, |
||||
VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE, |
||||
31 | 25484685 |
38 | 1 | |
Blood sodium decreased, Dizziness, Vision blurred, Headache, Blood pressure decreased, |
||||
OXCARBAZEPINE, ARIPIPRAZOLE, ALBUTEROL SULFATE, ALBUTEROL, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, |
||||
32 | 25486567 |
US |
2 | |
Vision blurred, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
33 | 25486850 |
CN |
||
Epilepsy, Dizziness, Nausea, Vomiting, Somnolence, Vision blurred, Drug ineffective, |
||||
LACOSAMIDE, LACOSAMIDE, |
||||
34 | 25487082 |
US |
77 | 1 |
Vision blurred, Vitreous floaters, |
||||
AVACINCAPTAD PEGOL, AVACINCAPTAD PEGOL, AVACINCAPTAD PEGOL, AVACINCAPTAD PEGOL, AVACINCAPTAD PEGOL, AVACINCAPTAD PEGOL, |
||||
35 | 25487429 |
US |
79 | 2 |
Swelling of eyelid, Vision blurred, |
||||
ONABOTULINUMTOXINA, |
||||
36 | 25487469 |
US |
69 | 1 |
Rectal haemorrhage, Bronchitis, Blood glucose fluctuation, Initial insomnia, Vision blurred, Nasopharyngitis, |
||||
VEDOLIZUMAB, |
||||
37 | 25487496 |
US |
||
Loss of consciousness, Limb injury, Joint injury, Headache, Vision blurred, Hordeolum, Wrong technique in product usage process, |
||||
LOTILANER OPHTHALMIC SOLUTION, ERYTHROMYCIN, MONTELUKAST, PREDNISONE, MYCOPHENOLIC ACID, MYCOPHENILIC ACID, PYRIDOSTIGMINE BROMIDE ORAL, ERGOCALCIFEROL, |
||||
38 | 25487501 |
US |
80 | 2 |
Vision blurred, Vitreous floaters, Eye pain, |
||||
AVACINCAPTAD PEGOL, AVACINCAPTAD PEGOL, AVACINCAPTAD PEGOL, AVACINCAPTAD PEGOL, AVACINCAPTAD PEGOL, AVACINCAPTAD PEGOL, |
||||
39 | 25487832 |
GB |
69 | 2 |
Epistaxis, Conjunctivitis, Glossodynia, Eye discharge, Mydriasis, Eye swelling, Headache, Vision blurred, |
||||
MONTELUKAST, AMLODIPINE, PREGABALIN, DOXYCYCLINE, DOXYCYCLINE HYCLATE, AMITRIPTYLINE HYDROCHLORIDE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, LISINOPRIL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, FUROSEMIDE, TIOTROPIUM BROMIDE, BUPRENORPHINE, ACETAZOLAMIDE SODIUM, ACETAZOLAMIDE, MIRTAZAPINE, |
||||
40 | 25487949 |
IN |
1 | |
Cystoid macular oedema, Vision blurred, |
||||
RANIBIZUMAB, |
||||
41 | 25488071 |
US |
2 | |
Arthralgia, Syncope, Dry throat, Headache, Amnesia, Cough, Procedural pain, Heart rate increased, Dyspnoea, Dizziness, Therapy non-responder, Hypoaesthesia, Hypotension, Abdominal discomfort, Hepatobiliary disease, Constipation, Feeling abnormal, Thinking abnormal, Dry mouth, Oropharyngeal pain, Nausea, Confusional state, Palpitations, Sensory disturbance, Vision blurred, Coordination abnormal, Cognitive disorder, Productive cough, Patient dissatisfaction with treatment, |
||||
TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5 PHOSPHATE SODIUM, DEXPANTHENOL AND NIACINAMIDE, LEVOTHYROXINE SODIUM, HYDROCHLOROTHIAZIDE, ERGOCALCIFEROL, ZINC, ZINC GLUCONATE, ZINC CHLORIDE, ALBUTEROL SULFATE, OXYGEN, 0XYGEN, MAGNESIUM, NAPROXEN SODIUM, NAPROXEN SODIUM TABLET, MUPIROCIN, MUPIROCIN CALCIUM, DOXYCYCLINE, DOXYCYCLINE HYCLATE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, |
||||
42 | 25488114 |
US |
44 | 2 |
Vision blurred, Insomnia, |
||||
SUZETRIGINE, SUZETRIGINE, |
||||
43 | 25488602 |
US |
83 | 1 |
Eye pain, Vision blurred, |
||||
AVACINCAPTAD PEGOL, AVACINCAPTAD PEGOL, AVACINCAPTAD PEGOL, AVACINCAPTAD PEGOL, AVACINCAPTAD PEGOL, AVACINCAPTAD PEGOL, |
||||
44 | 25488809 |
US |
2 | |
Vision blurred, |
||||
45 | 25488890 |
US |
||
Swelling, Brow ptosis, Migraine, Oedema, Eyelid ptosis, Vision blurred, Off label use, Underdose, |
||||
46 | 25488891 |
US |
||
Vision blurred, Off label use, |
||||
47 | 25488974 |
US |
||
Eyelid ptosis, Vision blurred, Eye swelling, Ocular discomfort, Underdose, Off label use, |
||||
48 | 25489048 |
FI |
33 | 2 |
Heart rate increased, Somnolence, Pharyngeal hypoaesthesia, Palatal disorder, Dysphagia, Nausea, Pharyngeal paraesthesia, Off label use, Paraesthesia oral, Fatigue, Vision blurred, Dry mouth, Respiratory failure, Hypoaesthesia oral, Dry eye, Dyspnoea, Dizziness, Hypotension, Cough, Headache, Muscular weakness, |
||||
ONABOTULINUMTOXINA, ONABOTULINUMTOXINA, |
||||
49 | 25489084 |
US |
56 | 2 |
Vision blurred, Visual impairment, Vitreous floaters, |
||||
SELADELPAR LYSINE, |
||||
50 | 25489494 |
US |
57 | 1 |
Visual impairment, Injection site urticaria, Condition aggravated, Injection site rash, Headache, Vision blurred, Injection site swelling, Condition aggravated, |
||||
DUPILUMAB, FLUTICASONE PROPIONATE, |
||||
51 | 25489521 |
US |
29 | 2 |
Dizziness, Dysgeusia, Hypoaesthesia, Dyspnoea, Hypoaesthesia oral, Vision blurred, Paraesthesia oral, Paraesthesia, |
||||
TRISODIUM CITRATE DIHYDRATE, COPPER, LEVOTHYROXINE, NASAL, SALINE, (SALINE), |
||||
52 | 25489590 |
IN |
57 | |
Cataract, Vitreous haemorrhage, Vision blurred, |
||||
RANIBIZUMAB, |
||||
53 | 25489619 |
US |
1 | |
Vision blurred, Arthralgia, Intentional product misuse, |
||||
DUPILUMAB, DUPILUMAB, |
||||
54 | 25490435 |
US |
45 | 1 |
Blood glucose increased, Dizziness, Vision blurred, Fall, |
||||
INSULIN LISPRO, |
||||
55 | 25490595 |
US |
70 | 2 |
Vision blurred, Genital herpes, |
||||
DUPILUMAB, |
||||
56 | 25493284 |
1 | ||
Vision blurred, Visual impairment, |
||||
LENALIDOMIDE, |
||||
57 | 25481596 |
US |
48 | 2 |
Vision blurred, |
||||
SEMAGLUTIDE, |
||||
58 | 25481639 |
EG |
38 | 2 |
Amnesia, Mobility decreased, Headache, Vision blurred, Hypoaesthesia, Pain, Deafness, Multiple sclerosis, |
||||
OCRELIZUMAB, |
||||
59 | 25481675 |
US |
76 | 2 |
Dizziness, Vision blurred, |
||||
PERFLUOROHEXYLOCTANE, |
||||
60 | 25481797 |
US |
55 | 1 |
Eye pain, Vision blurred, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
61 | 25481906 |
US |
||
Vision blurred, |
||||
CILTACABTAGENE AUTOLEUCEL, |
||||
62 | 25481942 |
US |
47 | 2 |
Eye irritation, Vision blurred, Pruritus, Injection site bruising, Swelling face, Eye pain, Impaired work ability, Drug interaction, |
||||
ADALIMUMAB, DUPILUMAB, DUPILUMAB, |
||||
63 | 25481949 |
US |
59 | 2 |
Vision blurred, |
||||
ABATACEPT, |
||||
64 | 25482511 |
TR |
66 | 2 |
Pain, Erythema, Vision blurred, Anterior chamber cell, Vitreous disorder, Off label use, |
||||
BEVACIZUMAB, |
||||
65 | 25483389 |
CN |
69 | 2 |
Contrast encephalopathy, Headache, Dizziness, Vision blurred, Delirium, Head discomfort, Blood pressure increased, Respiratory rate increased, |
||||
IOPROMIDE, IOPROMIDE, |
||||
66 | 25483639 |
US |
58 | 2 |
Mean cell volume decreased, Red cell distribution width decreased, Granulocyte count increased, Immature granulocyte count increased, Monocyte count increased, Eosinophil count decreased, Bradycardia, Glomerular filtration rate decreased, Mitral valve incompetence, Exophthalmos, Endocrine ophthalmopathy, Pericarditis, Flank pain, Iris disorder, Obesity, Blood creatinine increased, Protein total increased, Blood albumin increased, Aspartate aminotransferase increased, Ventricular extrasystoles, Peripheral arterial occlusive disease, Type V hyperlipidaemia, Dry eye, Nausea, Stress urinary incontinence, Pollakiuria, Diarrhoea, Vision blurred, Epistaxis, Prothrombin time prolonged, Reflux laryngitis, |
||||
TEPROTUMUMAB, TEPROTUMUMAB, TEPROTUMUMAB, TEPROTUMUMAB, TEPROTUMUMAB, TEPROTUMUMAB, PREDNISONE, PREDNISONE, ATROPINE SULFATE, ATROPINE, ACETAMINOPHEN AND CODEINE, COLCHICINE, OMEPRAZOLE MAGNESIUM, IOPAMIDOL, AMOXICILLIN AND CLAVULANATE POTASSIUM, METHOCARBAMOL, LATANOPROST, ERGOCALCIFEROL, DIAZEPAM, ATENOLOL, ASPIRIN, BARIUM SULFATE, COLCHICINE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, IBUPROFEN, MELOXICAM, ARTIFICIAL TEARS, LUBRICANT EYE DROPS, POLYVINYL ALCOHOL, POVIDONE, GLYCERIN, |
||||
67 | 25483946 |
FR |
59 | 2 |
Choroidal effusion, Oropharyngeal pain, Vision blurred, |
||||
METHOTREXATE SODIUM, UPADACITINIB, |
||||
68 | 25484137 |
US |
2 | |
Vision blurred, Visual impairment, Headache, Dacryostenosis acquired, Chalazion, Maternal exposure during pregnancy, Product use in unapproved indication, |
||||
DUPILUMAB, DUPILUMAB, |
||||
69 | 25484271 |
US |
2 | |
Photophobia, Eyelid margin crusting, Vision blurred, Eye inflammation, Dry eye, |
||||
DUPILUMAB, |
||||
70 | 25484295 |
US |
2 | |
Eye discharge, Vision blurred, Eye pruritus, Product use in unapproved indication, |
||||
DUPILUMAB, |
||||
71 | 25484406 |
CN |
18 | 2 |
Vision blurred, Diarrhoea, Hot flush, Feeling hot, Off label use, |
||||
CARBOPROST TROMETHAMINE, CARBOPROST TROMETHAMINE, |
||||
72 | 25484471 |
31 | 2 | |
Migraine, Vertigo, Anxiety, Withdrawal syndrome, Brain fog, Suicidal ideation, Depersonalisation/derealisation disorder, Derealisation, Nightmare, Arthralgia, Sciatica, Photophobia, Hyperacusis, Vision blurred, Tinnitus, Obsessive thoughts, Cognitive disorder, Pain in extremity, |
||||
MIRTAZAPINE, CITALOPRAM, DESVENLAFAXINE SUCCINATE, ESCITALOPRAM, TEMAZEPAM, DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), |
||||
73 | 25484540 |
68 | 2 | |
Eye pain, Eye pruritus, Vision blurred, Exophthalmos, Visual impairment, Photosensitivity reaction, Eye disorder, |
||||
AVACINCAPTAD PEGOL, GABAPENTIN, ALPRAZOLAM, FLUOXETINE HYDROCHLORIDE, FLUOXETINE, NICOTINE POLACRILEX, NICOTINE POLACRILEX GUM, NICOTINE, ERGOCALCIFEROL, |
||||
74 | 25484609 |
75 | 2 | |
Vision blurred, |
||||
LOTILANER OPHTHALMIC SOLUTION, |
||||
75 | 25484617 |
36 | 2 | |
Depression, Feeling abnormal, Paranoia, Feeling abnormal, Vision blurred, Psychomotor skills impaired, Hyperhidrosis, |
||||
ZURANOLONE, |
||||
76 | 25484639 |
36 | 1 | |
Hypersensitivity, Heart rate decreased, Blood pressure decreased, Hyperhidrosis, Flushing, Vision blurred, Immobile, Loss of consciousness, Pallor, Syncope, Anaphylactic shock, |
||||
77 | 25484868 |
US |
||
Vision blurred, |
||||
TIRZEPATIDE, |
||||
78 | 25485092 |
78 | ||
Fatigue, Vision blurred, |
||||
RUXOLITINIB, AMLODIPINE BESYLATE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, BUMETANIDE, SPIRONOLACTONE, LEVOTHYROXINE SODIUM, VALSARTAN, VALSARTAN ORAL, |
||||
79 | 25485299 |
US |
2 | |
Vision blurred, Arthralgia, |
||||
DUPILUMAB, DUPILUMAB, |
||||
80 | 25485385 |
IT |
||
Cataract, Product use complaint, Product dose omission issue, Lacrimation increased, Vision blurred, Ocular hyperaemia, |
||||
DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE, |
||||
81 | 25475926 |
CA |
52 | 2 |
Drug ineffective, Eye disorder, Headache, Injection site pain, Poor venous access, Retinal disorder, Sjogren^s syndrome, Vision blurred, |
||||
TOPIRAMATE, BELIMUMAB, HYDROXYCHLOROQUINE, PILOCARPINE HYDROCHLORIDE, |
||||
82 | 25476187 |
US |
||
Eyelid margin crusting, Eye pruritus, Lacrimation increased, Eye pain, Vision blurred, |
||||
CYCLOSPORINE OPHTHALMIC SOLUTION, |
||||
83 | 25476194 |
US |
2 | |
Dry eye, Vision blurred, Condition aggravated, |
||||
CYCLOSPORINE OPHTHALMIC SOLUTION, |
||||
84 | 25476290 |
AU |
71 | 1 |
Eye pain, Headache, Vision blurred, |
||||
SEMAGLUTIDE, SEMAGLUTIDE, SEMAGLUTIDE, HYDROCHLOROTHIAZIDE, AZELASTINE HYDROCHLORIDE AND FLUTICASONE PROPIONATE, OXYCODONE HYDROCHLORIDE, OXYCODONE, OXYCODONE HYDROCHLORIDE, OXYCODONE, MONTELUKAST, PREGABALIN, ROSUVASTATIN, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, SUMATRIPTAN, SUMATRIPTAN SUCCINATE, DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), GABAPENTIN, |
||||
85 | 25476572 |
US |
74 | 1 |
Lung neoplasm malignant, Dyspnoea, Ocular hyperaemia, Vision blurred, |
||||
DUPILUMAB, |
||||
86 | 25476904 |
US |
||
Vision blurred, |
||||
VIBEGRON, |
||||
87 | 25477570 |
US |
1 | |
Eye discharge, Vision blurred, |
||||
OLOPATADINE HYDROCHLORIDE, |
||||
88 | 25477582 |
US |
64 | 2 |
Wrong product administered, Vision blurred, |
||||
OLOPATADINE HYDROCHLORIDE, |
||||
89 | 25477585 |
US |
70 | 2 |
Product storage error, Vision blurred, |
||||
OLOPATADINE HYDROCHLORIDE, |
||||
90 | 25477588 |
US |
60 | 2 |
Drug ineffective, Loss of personal independence in daily activities, Visual impairment, Eye irritation, Eye pain, Vision blurred, |
||||
OLOPATADINE HYDROCHLORIDE, |
||||
91 | 25477590 |
US |
66 | 2 |
Product label issue, Vision blurred, |
||||
OLOPATADINE HYDROCHLORIDE, |
||||
92 | 25477631 |
US |
||
Product odour abnormal, Vision blurred, |
||||
93 | 25478058 |
US |
64 | 1 |
Drug ineffective, Disease progression, Vision blurred, Off label use, |
||||
OXALIPLATIN, PREDNISONE, FLUOROURACIL CREAM, 0.5%, FLUOROURACIL, TRASTUZUMAB, |
||||
94 | 25478422 |
US |
77 | |
Drug dose omission by device, Dry eye, Lacrimation increased, Vision blurred, Visual impairment, |
||||
TEZEPELUMAB-EKKO, |
||||
95 | 25478433 |
US |
2 | |
Eye irritation, Vision blurred, |
||||
CYCLOSPORINE OPHTHALMIC SOLUTION, |
||||
96 | 25478443 |
80 | 2 | |
Eye irritation, Eye irritation, Eye pruritus, Eye pain, Ocular hyperaemia, Lacrimation increased, Eye inflammation, Vision blurred, |
||||
LOTILANER OPHTHALMIC SOLUTION, SIMVASTATIN, ERYTHROMYCIN, CLOBETASOL PROPIONATE, CLOBETASOL PROPIONATE OINTMENT USP, 0.05%, ERGOCALCIFEROL, |
||||
97 | 25478783 |
US |
||
Vision blurred, Dry eye, |
||||
CYCLOSPORINE OPHTHALMIC SOLUTION, |
||||
98 | 25478811 |
US |
70 | 2 |
Eye irritation, Vision blurred, Ocular hyperaemia, |
||||
CYCLOSPORINE OPHTHALMIC SOLUTION, |
||||
99 | 25478815 |
US |
2 | |
Vision blurred, |
||||
CYCLOSPORINE OPHTHALMIC SOLUTION, |
||||
100 | 25478895 |
US |
2 | |
Vision blurred, Diplopia, Drug ineffective, |
||||
CYCLOSPORINE OPHTHALMIC SOLUTION, |
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2025-07-29